Inify Laboratories is a cutting-edge brand that specializes in providing cancer diagnostics through ultramodern laboratory services within pathology. They are at the forefront of innovation, utilizing a fully digital, standardized, and AI-supported workflow to optimize the quality and response times of their services. Initially focused on prostate cancer diagnosis, their concept is scalable and can be extended to other diagnoses in the future.

At Inify Laboratories, their comprehensive service covers the entire chain of sample handling, including logistics, sample preparation, and reporting by experienced pathologists. Their reports are assisted by their own AI technology, which has been clinically proven to have world-leading accuracy. As an independent company based in Sweden, Inify Laboratories has over 40 years of experience within digital imaging for medical applications.

They are listed on Euronext Growth Oslo under the ticker INIFY. With a commitment to excellence and accuracy, Inify Laboratories is dedicated to revolutionizing the field of pathology and providing high-quality cancer diagnostic services